Industry X.0 for Life Sciences manufacturers
June 26, 2018
Accenture's recent global research study of 931 executives, including 140 life sciences manufacturing executives, looked to understand existing investments in digital technologies, and the challenges to drive value with such investments.
Pharmaceutical and MedTech respondents agreed that innovation and leading-edge technologies are essential to drive growth, however they differ in their top priorities.
In pharma, top priorities were:
In MedTech, the top priorities were:
of Medtech companies are completely ready
of Pharma companies are completely ready
Companies can do more than just change themselves into digital businesses; they can completely reinvent their operating models, production and value chains to create more value with digital. Our research yields a concrete solution: what we call Industry X.0. It’s an action plan for becoming more adept at embracing technological change and profiting from it.
Our research reveals six digital imperatives pharma and medtech companies should focus on to become smart, connected, living and learning.
Learn more about the research findings and how you can unlock the power of digital to completely reinvent your business.